人工尿道括约肌与可膨胀阴茎假体联合置入不增加围手术期并发症风险,也不影响装置长期存活
基于监测、流行病学和最终结果(SEER)医疗保险数据库2002至2016年数据,纳入37,599例根治性前列腺切除术后男性,比较同期联合置入可膨胀阴茎假体(IPP)与人工尿道括约肌(AUS)与单独置入的围手术期并发症及装置长期存活。联合置入不增加并发症风险,也不影响装置存活。
要点
- 联合置入组与单独置入组的30天和90天并发症发生率无差异。
- 中位随访61个月,联合置入未影响装置长期存活。
- 联合置入组相对单独AUS置入组更年轻(68.8岁 vs 70.2岁,P=0.03)。
核心结论
- 联合置入AUS和IPP与单独置入任一装置相比,不增加围手术期并发症,也不影响装置存活。
研究设计与样本
- 回顾性队列研究,数据来自监测、流行病学和最终结果(SEER)医疗保险数据库2002至2016年,纳入65岁以上根治性前列腺切除术后男性37,599例。
主要发现
- AUS置入793例(2.1%),IPP置入644例(1.7%),联合置入62例(0.2%)。
- 联合置入组相对单独AUS置入组更年轻(68.8岁 vs 70.2岁,P=0.03),Charlson合并症指数、肿瘤分级和既往放疗率相当。
- 相对单独IPP置入组,接受辅助或挽救性放疗者更可能行联合置入。
- 置入后30天和90天内并发症发生率组间无差异。
- 中位随访61个月,Kaplan-Meier分析显示联合置入相对单独装置置入未影响长期装置存活。
关键数值与推荐
- 联合置入定义为同一天置入IPP和AUS,由现行操作术语(CPT)代码确定。
- 装置存活通过装置取出、更换和/或修复的CPT代码评估。
- 并发症通过ICD-9代码评估置入后90天内。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To determine the impact of concurrent inflatable penile prosthesis (IPP) and artificial urinary sphincter (AUS) implantation on perioperative complications and long-term device survival, among men with postprostatectomy erectile dysfunction and urinary incontinence. METHODS: We identified men older than 65 treated with radical prostatectomy in the Surveillance, Epidemiology, and End Results Medicare database between 2002 and 2016. IPP or AUS placement was determined by current procedural terminology (CPT) code, with dual implantation (DI) defined as IPP and AUS placement on the same date. Device survival was assessed using CPT codes for device removal, replacement, and/or repair. Complications were assessed within 90 days using ICD-9 codes. Statistical analysis was performed using SAS v9.3 (Cary, NC). RESULTS: A total of 37,599 men underwent radical prostatectomy, with AUS placed in 793 (2.1%), IPP placed in 644 (1.7%), and DI in 62 (0.2%). Relative to AUS placement alone, men undergoing DI were younger (68.8 vs 70.2 years, P = 0.03), but had equivalent Charlson comorbidity index, tumor grades, and rates of prior radiotherapy. Relative to IPP placement alone, men were more likely to undergo DI if treated with adjuvant or salvage radiotherapy. The incidence of complications within 30 and 90 days of prosthetic implantation did not differ between groups. Long-term device survival on Kaplan-Meier analysis was not impacted by DI relative to single device implantation with median follow-up of 61 months. CONCLUSION: Combined AUS and IPP placement does not adversely affect perioperative complications or device survival relative to placement of either device alone.
引用
- Boysen WR, Cohen AJ, Kuchta K, et al. Combined Placement of Artificial Urinary Sphincter and Inflatable Penile Prosthesis Does Not Increase Risk of Perioperative Complications or Impact Long-term Device Survival. Urology. 2018. PMID: 30786981. doi:10.1016/j.urology.2018.10.033
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。